Excellent Outcome for Pediatric Patients with High Risk Hodgkin Lymphoma with Brentuximab Vedotin and Risk Adapted Residual Node RadiationMonika L. Metzger, Matthew J. Krasin, Amy L. Billett et al.|SSRN Electronic Journal|2020Cited by 0